Hsbc Holdings PLC Fate Therapeutics Inc Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 109,422 shares of FATE stock, worth $155,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,422
Previous 89,716 21.96%
Holding current value
$155,379
Previous $314,000 42.68%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.61 - $3.35 $31,726 - $66,015
19,706 Added 21.96%
109,422 $180,000
Q3 2024

Nov 14, 2024
BUY
$3.12 - $5.57 $3,750 - $6,695
1,202 Added 1.36%
89,716 $314,000
Q2 2024

Aug 12, 2024
BUY
$3.26 - $7.08 $73,620 - $159,887
22,583 Added 34.25%
88,514 $290,000
Q1 2024

May 15, 2024
SELL
$3.54 - $8.35 $45,368 - $107,013
-12,816 Reduced 16.27%
65,931 $483,000
Q4 2023

Feb 12, 2024
SELL
$1.65 - $3.94 $52,214 - $124,681
-31,645 Reduced 28.67%
78,747 $294,000
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $151,578 - $378,196
75,039 Added 212.26%
110,392 $234,000
Q2 2023

Aug 11, 2023
SELL
$4.76 - $6.59 $33,581 - $46,492
-7,055 Reduced 16.64%
35,353 $168,000
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $5,893 - $15,456
-1,390 Reduced 3.17%
42,408 $241,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $184,391 - $445,644
18,701 Added 74.51%
43,798 $441,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $307,667 - $527,305
14,623 Added 139.61%
25,097 $578,000
Q2 2022

Aug 11, 2022
BUY
$17.78 - $42.39 $37,924 - $90,417
2,133 Added 25.57%
10,474 $258,000
Q1 2022

May 16, 2022
BUY
$29.67 - $60.28 $247,477 - $502,795
8,341 New
8,341 $331,000
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $250,297 - $404,267
-4,223 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$67.25 - $92.52 $283,996 - $390,711
4,223 New
4,223 $366,000
Q4 2020

Feb 12, 2021
SELL
$38.09 - $100.95 $471,973 - $1.25 Million
-12,391 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$30.41 - $40.5 $105,249 - $140,170
-3,461 Reduced 21.83%
12,391 $502,000
Q2 2020

Aug 14, 2020
BUY
$20.21 - $35.23 $112,630 - $196,336
5,573 Added 54.22%
15,852 $544,000
Q1 2020

May 15, 2020
BUY
$17.28 - $31.88 $177,621 - $327,694
10,279 New
10,279 $233,000

Others Institutions Holding FATE

# of Institutions
167
Shares Held
108M
Call Options Held
79.2K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $138M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email